In our study, we showed through MDR analysis that there is an interplay among H19 (rs3741219), IGF2BP2 (rs1470579), and IGF2 (rs680), indicative of the interactive role of these polymorphisms in MetS occurrence, which is consistent with the abovementioned reports. This evidence concerns the gene H19 and metabolic syndrome.